Status:
NOT_YET_RECRUITING
Measurement of MMP-14 Protein, a Potential New Marker for Colorectal Cancer Detection, in Plasma Vesicles Named Exosomes
Lead Sponsor:
CHU de Reims
Conditions:
Colorectal Adenocarcinoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Colorectal cancer is the third most common cancer in men, and the second most common in women. Screening for colorectal cancer is based on the search for blood in the stool using fecal immunochemical ...
Detailed Description
Inclusion criteria: Individuals presenting for colonoscopy with a positive FIT result. * Positive fecal immunoassay requiring total colonoscopy under general anesthesia. * Persons having agreed to pa...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Individuals presenting for colonoscopy with a positive FIT result.
- Positive fecal immunoassay requiring total colonoscopy under general anesthesia.
- Persons having agreed to participate in the study (signed consent form)
- Adults affiliated to a health insurance scheme.
- Exclusion criteria:
- History of other cancer not in remission or in remission for less than five years (with the exception of cervical cancer or basal cell skin cancer treated with curative intent)
- Patients undergoing chemotherapy
- Legally protected individuals
Exclusion
Key Trial Info
Start Date :
May 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2027
Estimated Enrollment :
650 Patients enrolled
Trial Details
Trial ID
NCT06955767
Start Date
May 1 2025
End Date
May 1 2027
Last Update
May 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Damien JOLLY
Reims, France